Filter Results:
(217)
Show Results For
- All HBS Web (341)
- Faculty Publications (138)
Show Results For
- All HBS Web (341)
- Faculty Publications (138)
Sort by
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
example here. More business leaders in the health care sector recognize that industry actors that engage in egregious pricing of drugs bring all kinds of problems to the whole industry. Silverthorne: You note that companies by themselves... View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
iPhoto With billions of dollars spent on the development of precision medicine and related cancer research over the last decade, a recent partnership seeks a new way to bring these treatments to patients more quickly: through a better... View Details
- 03 Oct 2006
- First Look
First Look: October 3, 2006
considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
to standardize their products and helped establish brand identities through consistent appearance. By 1938, food dyes had achieved such widespread use, and had raised such public concern, that the federal government amended the 1906 Pure Food and View Details
Keywords: Carmen Nobel
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers worldwide set up drive-through testing sites, makeshift View Details
Keywords: by Danielle Kost
- 04 Feb 2014
- First Look
First Look: February 4
Course overview of The Entrepreneurial Manager. Purchase this case: http://hbr.org/product/the-entrepreneurial-manager-course-overview-2014-winter-term-course-overview-note/an/814064-PDF-ENG Harvard Business School Case 814-003 FasterCures: Removing Barriers to View Details
Keywords: Sean Silverthlorne
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
information in online retail. In our experiments, customers are randomly assigned to a treatment condition where virtual fit information is available or to a control condition where virtual fit information is not available. Our results... View Details
Keywords: Dina Gerdeman
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
interrelated. People who have studied this industry for a long time have come up with a number of feasible ideas to get at the cost problem, including high-deductible insurance and health savings accounts. But until we make sure that the View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
watch a series of real, crime-related videos (while the control group watches non-crime-related videos). Not previously victimized participants exposed to the treatment video show significant changes in cortisol level, heart rate, and... View Details
Keywords: Sean Silverthorne
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of... View Details
Keywords: by Julia Hanna
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
for All published by the Harvard Business Review. [Image: Hispanolistic] Related Reading Germany May Have the Answer for Reducing Drug Prices What Hospitals Must Learn to Compete Making Health Insurance That Consumers Actually Like What... View Details
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
people? One possible answer came this past week when the airline revealed that the pilot, Andreas Lubitz, had previously suffered from deep depression. Debates began about how Lubitz's mental health played into the tragedy, what treatment... View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow View Details
Keywords: by Regina E. Herzlinger
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 28 Jul 2015
- First Look
First Look: July 28, 2015
of Dublin, Ireland-based Elan Drug Technologies (EDT)-a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case... View Details
Keywords: Carmen Nobel